Top Markets
Coin of the day
Hemcheck Sweden AB (publ) Hemcheck Sweden AB (publ)

Hemcheck Sweden AB (publ)

HEMC
Rank in Stocks #39792
Hemcheck Sweden AB (publ) is a Swedish medical technology company. They... Hemcheck Sweden AB (publ) is a Swedish medical technology company. They specialize in developing and marketing Helge, a device capable of identifying hemolysis in blood samples at the point of care. The company's services are primarily aimed at emergency departments within the European Union and the United States. Hemcheck was founded in 2010 and is based in Karlstad, Sweden.
Share Price
$0.02447314
Last synced: 2024-01-02
Market Cap
$346.96K
Change (1 day)
3.58%
Change (1 year)
0.00%
Country
SE
Trade Hemcheck Sweden AB (publ) (HEMC)

Category

P/E ratio for Hemcheck Sweden AB (publ) (HEMC)
P/E ratio as of 2026 TTM: 0
According to Hemcheck Sweden AB (publ) latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Hemcheck Sweden AB (publ) from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
33.99 -
US
33.47 -
US
21.39 -
IE
18.84 -
US
49.47 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.